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Abstract
Background: We have previously demonstrated that increased rates of superoxide generation by extra-
mitochondrial enzymes induce the activation of the mitochondrial ATP-sensitive potassium channel (mitoKATP) in
the livers of hypertriglyceridemic (HTG) mice. The resulting mild uncoupling mediated by mitoKATP protects
mitochondria against oxidative damage. In this study, we investigate whether immune cells from HTG mice also
present increased mitoKATP activity and evaluate the influence of this trait on cell redox state and viability.
Methods: Oxygen consumption (Clark-type electrode), reactive oxygen species production (dihydroethidium and
H2-DCF-DA probes) and cell death (annexin V, cytocrome c release and Trypan blue exclusion) were determined in
spleen mononuclear cells.
Results: HTG mice mononuclear cells displayed increased mitoKATP activity, as evidenced by higher resting
respiration rates that were sensitive to mitoKATP antagonists. Whole cell superoxide production and apoptosis rates
were increased in HTG cells. Inhibition of mitoKATP further increased the production of reactive oxygen species and
apoptosis in these cells. Incubation with HTG serum induced apoptosis more strongly in WT cells than in HTG
mononuclear cells. Cytochrome c release into the cytosol and caspase 8 activity were both increased in HTG cells,
indicating that cell death signaling starts upstream of the mitochondria but does involve this organelle.
Accordingly, a reduced number of blood circulating lymphocytes was found in HTG mice.
Conclusions: These results demonstrate that spleen mononuclear cells from hyperlipidemic mice have more active
mitoKATP channels, which downregulate mitochondrial superoxide generation. The increased apoptosis rate
observed in these cells is exacerbated by closing the mitoKATP channels. Thus, mitoKATP opening acts as a
protective mechanism that reduces cell death induced by hyperlipidemia.
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Background
Circulating free fatty acids (FFA) may modulate immune
cell functions when certain types are present at high
levels. They can act either directly or by generating
biologically active metabolites to regulate key metabolic
and immune responses in lymphocytes, neutrophils and
monocyte-macrophages. Fatty acids can modulate intra-
cellular signaling pathways by changing cell membrane
fluidity, the composition of lipid rafts and the produc-
tion of second messengers. In addition, fatty acids can
act on receptors in either the cell membrane or the
nucleus, such as the toll-like receptors (TLRs) and the
peroxisome-proliferator-activated receptors (PPARs),
respectively. Common outcomes of fatty acid action on
biological systems are stimulation of the production of
eicosanoids, reactive oxygen species (ROS) and reactive
nitrogen species, which may induce cell death [1].
Previous studies have demonstrated the induction of
leukocyte death or proliferation suppression when these
cells are exposed to high levels of FFA in vitro or
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obtained from animals fed high-fat diets. Several reports
have indicated that fatty acids, particularly unsaturated
fatty acids, can compromise leukocyte immune function,
including cell proliferation, production of cytokines and
natural killer cell activity [2,3]. However, the amount of
fatty acids given in animal studies or the concentrations
of FFA used in the cell culture studies often greatly
exceed the amounts found in in vivo physiopathological
conditions, which limits the biological significance of
these results.
Transgenic mice overexpressing the apolipoprotein
(apo) CIII exhibit markedly elevated plasma levels of tri-
glycerides (TG), in addition to a ~2-fold increase in FFA
levels, even on a very-low-fat diet [4,5]. Under normal
laboratory controlled conditions, these mice are perfectly
healthy. They present normal glucose homeostasis [6,7],
as well as normal body mass and weight gain [8]. There-
fore, these mice are useful models to study the effects of
hyperlipidemia on cell function independently of sec-
ondary factors induced by high-fat diets, such as insulin
resistance and obesity. Their hypertriglyceridemia is a
consequence of the impaired liver removal of apo CIII-
rich and TG-rich lipoproteins by their specific liver re-
ceptors [5]. Thus, the extended permanence of TG-rich
lipoproteins in the plasma results in continuous FFA
release to the plasma and tissues.
We have previously used these hypertriglyceridemic
mice (HTG mice) to investigate the effects of hyperlipid-
emia on liver mitochondrial bioenergetics and redox
state. We have found that liver mitochondria from HTG
mice present increased resting respiration rates and re-
duced hydrogen peroxide release through a mechanism
that is independent of uncoupling proteins or adenine
nucleotide translocase activities and is related to the in-
creased activity of mitochondrial ATP-sensitive K+ chan-
nels (mitoKATP) [8-10]. This increased mitoKATP activity
was also present in the brain but not the skeletal muscle
of HTG mice [11]. MitoKATP activity results in a mild
mitochondrial uncoupling that has little or no effect
on oxidative phosphorylation efficiency [12]. Overall,
this mitochondrial uncoupling process results in the
increased consumption of substrates (including FFA),
faster electron flow through respiratory chain complexes
and less mitochondrial superoxide production [13,14].
We proposed that the increase in mitoKATP activity is a
cell adaptation to reduce both intracellular FFA levels
and mitochondrial superoxide generation [8].
This study was designed to investigate whether
immune cells from HTG mice also present increased
mitoKATP activity and how this activity influences the
cell redox state and viability. Spleen mononuclear cells
were chosen because they represent circulating blood
lymphomononuclear cells and, in addition, these cells
are relevant for atherosclerosis development in the
hyperlipidemic context. Moreover, mitoKATP channels
were already identified in a human T cell lymphoblast-like
cell line (Jurkat cells) and display the main features of the
mitoKATP channels found in the liver, e.g., they are blocked
by ATP and selectively inhibited by 5-hydroxidecanoate
[15]. We hypothesized that elevated TG and FFA levels
induce an increase in mitoKATP activity, as observed in the
liver, resulting in the protection of HTG mononuclear
cells against oxidative stress and cell death.
Results
Oxygen consumption by spleen mononuclear cells was
measured under resting (non-phosphorylating) conditions
to evaluate whether increased mitoKATP activity was
present in HTG cells, as previously observed in liver mito-
chondria [8-10]. Figure 1 shows that oxygen consumption
rates were approximately 40% higher in HTG cells than in
WT cells under conditions where oxidative phosphoryl-
ation and NADPH oxidase were inhibited by oligomycin
and diphenylene iodonium (DPI), respectively [16].
This increase in resting respiration was inhibited by
two mitoKATP antagonists, i.e., glibenclamide (glyburide,
GLYB) and 5-hydroxidecanoate (5-HD), indicating higher
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Figure 1 Enhanced resting respiration in spleen mononuclear
cells from HTG mice is due to the mitochondrial ATP-sensitive
K+ channel (mitoKATP). HTG and WT cells (1.5 × 10
7 cells.ml-1) were
added to RPMI 1640 medium containing 25 mM HEPES pH 7.4, 1%
FBS, 1 μg/ml oligomycin and 10 μM DPI, in the absence (control) or
presence of 1 mM 5-hydroxidecanoate (5HD) or 10 μM glibenclamide
(GLYB) at 37°C. The results are expressed as means ± SEM, n = 6.
*P < 0.01 vs WT; #P < 0.05 vs. HTG under control conditions.
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levels and/or activity of the mitoKATP channel in spleen
mononuclear cells from HTG mice. No effects were
observed in WT cells after treatment with mitoKATP
antagonists, indicating low levels or activity of this channel
in these cells.
In lymphocytes, NADPH oxidase and mitochondria
are the main cellular sources of ROS generation [17,18].
Mitochondrial ROS production is modulated by respira-
tory rates. In general, faster respiratory rates, such as
those found when uncoupling pathways are activated,
are accompanied by lower levels of ROS release [13]. To
specifically assess mitochondrial ROS production and its
potential modulation via mitoKATP uncoupling [12], we
conducted experiments in the presence of DPI to inhibit
superoxide (O2
•-) production via NADPH oxidase
(control conditions). Under these conditions, using the
membrane permeable non-specific probe H2-dichloro-
fluorescein-diacetate (H2DCF-DA), we found similar
mitochondrial ROS production in HTG and WT intact
mononuclear cells (Figure 2). However, when mitoKATP
was closed by 5-HD or GLYB (Figure 2), increased mito-
chondrial ROS production was observed in HTG cells
compared to the production in the respective control
cells. These results suggest that high mitoKATP activity
modulates mitochondrial ROS generation in intact
spleen mononuclear cells from HTG mice.
Next, we evaluated the role of increased mitoKATP
activity on HTG mononuclear cell viability. The percent-
age of apoptotic cells was estimated using annexin V
staining under the same conditions used to measure O2
consumption and ROS production. DPI was present to
ensure that apoptosis pathways would not be induced by
NADPH oxidase-generated ROS. Figure 3 shows that
apoptosis levels were 2-fold higher in HTG than WT
cells (control condition). Apoptosis in HTG cells was
further increased in the presence of the mitoKATP antag-
onists 5-HD and GLYB (close to 3-fold higher in HTG
than WT cells), while no changes in the apoptosis rates
were observed in WT cells in the presence of these com-
pounds. No significant levels of necrosis were detected
in either type of cells (data not shown). These results
indicate that increased mitoKATP activity partially
prevents apoptotic cell death in HTG mononuclear cells.
Apoptosis can be induced by mitochondrial (intrinsic)
and/or cell death receptor dependent (extrinsic) path-
ways, which can be respectively characterized by cyto-
chrome c release and caspase 8 activation. We evaluated
which of these pathways were involved in the apoptotic
process in spleen mononuclear cells from HTG mice.
Western blotting analyses of cell fractions showed larger
quantities (~ 60%) of cytochrome c released into the
cytosol of HTG cells in comparison with WT cells
(Figure 4). In addition, we found approximately 70%
higher caspase 8 activity in HTG cells (15.06 ± 2.19 pmol
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Figure 2 MitoKATP decreases mitochondrial ROS generation in
spleen mononuclear cells from HTG mice. HTG and WT cells
(6 × 106 cells.ml-1) were added to HANKS medium pH 7.4 containing
10 μM DPI and 1 μM H2DCF-DA in the absence (control) or presence
of 1 mM 5HD or 10 μM glibenclamide (GLYB) at 37°C. The results are
expressed as means ± SEM, n = 9. *P < 0.01 vs. HTG under
control conditions.
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Figure 3 MitoKATP opening partially prevents enhanced
apoptotic cell death in spleen mononuclear cells from HTG
mice. HTG and WT cells (106 cells) were incubated for 20 min in
binding buffer containing annexin V-FITC and 7-AAD, 10 μM DPI, at
37°C, in the absence (control) or presence of 1 mM 5HD or 10 μM
GLYB, as described in the Materials and Methods Section. The results
are expressed as means ± SEM, n = 5. *P < 0.01 vs. WT under same
conditions; #P < 0.05 vs. HTG under control conditions.
Alberici et al. Lipids in Health and Disease 2013, 12:87 Page 3 of 9
http://www.lipidworld.com/content/12/1/87
AFC. 106 cells-1) than in WT cells (9.03 ± 1.3 pmol AFC.
106 cells-1). These results indicate that apoptosis in HTG
cells may be triggered by the extrinsic pathway upstream
of the mitochondria but that these organelles are in-
volved in the downstream stages of apoptosis.
The increased levels of apoptotic cell death of HTG
cells could be related to the process of immune cell acti-
vation, which involves (i) the influx of extracellular Ca2+
[17,19] and (ii) Ca2+-dependent activation of nuclear fac-
tors that upregulate genes encoding cytokines, such as
IL-2, which is involved in cell cycle progression [20,21].
To test these possibilities, cytosolic free Ca2+ concentra-
tions and IL-2 levels were measured in the spleen mono-
nuclear cells of HTG mice. We found similar cytosolic
free Ca2+ concentrations in both cell types (47.52 ± 2.45
and 50.46 ± 2.73 nM for WT and HTG, respectively) as
well as very low but similar IL-2 levels in both cells
(5.55 ± 1.62 and 5.85 ± 1.07 pmol.mg-1 for WT and HTG,
respectively). These results indicate that the higher
apoptosis levels in HTG cells were not related to the
process of spleen mononuclear cell activation.
Previous studies suggested a significant relationship
between peripheral human T cell anisotropy and plasma
TG concentrations that was associated with the irrevers-
ible impairment of T cell proliferation and enhanced T
cell apoptosis [22]. To evaluate whether the increased
plasma lipid concentrations in HTG mice are the main
inducers of cell death in spleen mononuclear cells, we
compared cells incubated in media containing 10% fetal
bovine serum or serum from WT or HTG mice (Figure 5).
We found that, in the presence of normolipidemic serum
(fetal bovine serum or WT serum), HTG cells presented
higher cell death compared to WT cells (as observed in
Figure 3). Conversely, when cells were incubated in the
presence of the hyperlipidemic serum (HTG serum), we
observed higher rates (74%) of death for WTcells than ob-
served with normolipidemic serum. Under the same ex-
perimental conditions, hyperlipidemic serum elevated
superoxide production by WT cells compared to
normolipidemic serum (Figure 6). The presence of serum
from HTG mice rendered the superoxide release in WT
cells sensitive to the mitoKATP blocker 5HD, as observed
in the HTG cells (Figure 6). These results indicate that
components from HTG serum induce superoxide gener-
ation, activate mitoKATP and induce cell death in spleen
mononuclear cells.
As the spleen is a site for the storage and rapid
deployment of mononuclear cells [23], we investigated
whether the enhanced susceptibility to apoptosis ob-
served in the HTG spleen mononuclear cells could
impact the levels of circulating mononuclear cells. In
fact, we found that total white blood cell (WBC) counts
in the peripheral blood were reduced by approximately
30% in HTG mice (Table 1). Among the main types of
white cells, only lymphocyte counts showed a significant
reduction in HTG peripheral blood compared to the
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Cyt          Mit           Cyt          Mit        
cytochrome c 
(15 KDa)
VDAC 
(31 KDa)
WT HTG
0
2000
4000
6000
8000
10000
12000
a
rb
itr
ar
y 
un
its
*
Figure 4 Increased levels of cytochrome c in the cytosol of
spleen mononuclear cells from HTG mice. The cytochrome c
content of mitochondrial (Mit) and cytosolic (Cyt) extracts were
determined by Western blotting after 12% SDS-PAGE and staining
with anti-cytochrome c antibody (~ 15 kDa), as described in the
Materials and Methods Section. VDAC was used as the fraction
purity control. The results are expressed as means ± SEM, n = 4.
*P < 0.05 vs. WT.
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Figure 5 Serum from HTG mice induces death in spleen
mononuclear cells. Cells (106 cels.ml-1) were incubated for 4 h in
RPMI 1640 medium containing 10% fetal bovine serum (FB Serum)
or serum obtained from WT (WT Serum) or HTG (HTG Serum) mice.
Cells were counted using a Neubauer chamber, using trypan blue to
stain dead cells. The results are expressed as means ± SEM, n = 4.
*P < 0.05 vs. WT in the same serum; #P < 0.05 vs. WT in WT serum.
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level observed in WT blood. These results provide
evidence of leukopenia in HTG mice.
Discussion
The immune system cells have been shown to be im-
paired in several models of metabolic disorders, such as
diabetes [24-26], obese-diabetic db/db mice [27], obese
subjects [28], and genetically obese Zucker rats [29].
However, in these metabolic diseases, the co-existence
of insulin resistance, disturbed lipid metabolism and
chronic low grade inflammation impairs the determin-
ation of the relative contributors and the respective
underlying mechanisms. In this regard, the HTG animal
model studied here presents the advantage of a clean
hyperlipidemia phenotype due to genetic manipulation.
In previous studies, we showed that the larger intracel-
lular pool of FFA and TG in the livers of HTG mice was
associated with increased mitochondrial resting respira-
tory rates due to enhanced mitoKATP but not UCP activ-
ity [8,9]. This condition resulted in higher tissue and
whole body oxygen consumption [8] and less ROS
generation by the mitochondria [10,11]. In the present
study, we demonstrated that spleen mononuclear cells
from HTG mice also presented higher mitoKATP channel
activity, as the enhanced O2 consumption was sensitive
to the mitoKATP antagonists 5HD and glibenclamide. As
observed in the liver, mitoKATP activity also reduces
mitochondrial superoxide production in HTG spleen
mononuclear cells. A major finding of this work is that
mitoKATP closure exacerbates apoptosis in these cells.
Both extrinsic and intrinsic (mitochondrial) pathways
seem to be involved in the apoptosis of HTG cells, as
shown by caspase-8 activity and cytochrome c release to
the cytosol. These two pathways could be connected
through the cleavage and activation of the proapoptotic
protein Bid, which is downstream of the caspase-8 step
and upstream of the mitochondria [30,31]. Alternatively,
both extrinsic and intrinsic pathways may occur
independently and concurrently.
The serum reconstitution experiments detailed here
show that components of HTG serum enhance apop-
tosis in WT cells. FFAs are believed to be the principal
toxic trigger mediating the adverse cellular effects of
lipids. In high concentrations, they are well known
inducers of cell death in a variety of cell types. FFAs
modulate the expression of several genes related to the
cell cycle, apoptosis, proliferation, and oxidative stress
in leukocytes in a dose- and type-dependent manner
[32-36]. Several mechanisms of FFA-induced apoptosis
have been proposed, mostly involving mitochondria,
either directly [37-39] or at downstream steps of ROS-
induced signaling pathways [38,40-44]. The cross-talk
between mitochondria and both NADPH oxidase and
xanthine oxidase [10,45] are of particular interest in the
case of the HTG model because we have previously
shown elevated activity of these two oxidases in the
livers of HTG mice [10]. Considering that superoxide
radicals and H2O2 can activate mitoKATP in vitro
[46,47], we proposed that excess FFA activates the extra-
mitochondrial oxidases and that the resulting superoxide
radicals activate mitoKATP, which in turn decreases mito-
chondrial superoxide generation. This proposal is fully
supported by data that demonstrate that in vivo antioxi-
dant treatment of HTG mice reversed whole liver oxida-
tive damage, decreased mitoKATP opening and restored
mitochondrial resting respiration [10]. Therefore, we
have proposed mitoKATP as a redox sensor that allows
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Figure 6 Blood serum from HTG mice induces superoxide
generation in spleen mononuclear cells. Representative plots
from flow cytometry analyses are shown in A, and means ± SEM are
depicted in B. Cells (106 cells.ml-1) were incubated for 4 h in RPMI
1640 medium containing 10% serum obtained from WT (WT Serum)
or HTG (HTG Serum) mice. Green line: WT cells in WT serum; blue
line: HTG cells in WT serum; red line: WT cells in HTG serum; and
yellow line: HTG cells in HTG serum. *P < 0.05 for 5HD vs. respective
control condition. The results are expressed as means ± SEM, n = 9.
#P < 0.05 vs. control WT cells in WT serum.
Table 1 White blood cells (WBC) counts in blood from WT
and HTG mice
WBC neutrophils lymphocytes monocytes
WT 6.7 ± 0.4 0.7 ± 0.1 5.8 ± 0.4 0.05 ± 0.02
HTG 4.8 ± 0.7* 0.7 ± 0.1 4.0 ± 0.7* 0.04 ± 0.03
Averages ± SEM, n = 8. Values are expressed in 103 cells/mm3. *p < 0.05 vs WT.
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for cross-talk between extra- and intra-mitochondrial
compartments [10]. Accordingly, in the present work,
we showed that serum from HTG mice induces super-
oxide radical production in WT cells, which is further
upregulated by the mitoKATP blocker 5HD, indicating
that hyperlipidemia induces ROS generation and
activates mitoKATP.
MitoKATP opening has previously been studied in the
context of ischemia-reperfusion vascular damage. Sev-
eral evidences have shown that pharmacological opening
of mitoKATP protects against ischemic oxidative damage.
However, the signals and mechanisms of activating the
channel in vivo are still a matter of debate. Andrukhiv
et al. [48] showed that when heart mitochondria were
treated with the mitoKATP channel openers diazoxide or
cromakalim, their ROS production increased by 40-50%,
and this effect was blocked by 5-hydroxydecanoate.
Thus, these authors propose that the mitoKATP leads to
cardioprotection through an increase in ROS produc-
tion. On the other hand, Facundo et al. [49] reported an
enhancement of mitoKATP activity by treating heart
mitochondria with H2O2 and an impairment of
diazoxide-mediated activation of these channels by redu-
cing agents. Thus, these authors propose that ROS pro-
duction in reperfusion condition activates mitoKATP
which then prevent further oxidative stress under this
pathological condition. Accordingly, Queliconi et al. [7]
showed that mitoKATP is directly activated by several
(but not all) oxygen and nitrogen species in isolated
heart mitochondria and that this redox modulation
of mitoKATP may be the underlying mechanism for
cardioprotection in ischemic preconditioning. Although
the controversy about the effects of mitoKATP on ROS
release remains [45,47-49], our previous and present
data fit best in a view where mitoKATP activity represents
a homeostatic mechanism that avoids amplifying the
ROS production inside the cell [14,49,50].
FFA-induced apoptosis may be prevented by decreas-
ing mitochondrial oxidative stress; for example, carnitine
prevents FFA-induced apoptosis in HepG2 cells by in-
creasing mitochondrial oxidation and reducing oxidative
stress [51]. This is also confirmed here by the exacerba-
tion of apoptosis after closing mitoKATP (Figure 3) and
by the upregulation of ROS production upon mitoKATP
blocking in WT and HTG cells exposed to HTG serum
(Figure 6). In agreement with our results and proposal,
nicorandil, a clinical drug used to treat ischemic heart
disease, has been shown to protect cardiomyocytes from
apoptosis by activating mitoKATP channels [52]. In
addition, the nicorandil-induced opening of mitoKATP
channels suppressed ROS-induced apoptosis in cultured
cerebellar granule neurons [53].
Even when partially protected against apoptosis by
mitoKATP activation, HTG mononuclear cells present
higher rates of apoptosis under basal conditions. This
finding may explain the lymphocytopenia observed in
the blood of the HTG mice (30% reduction in total
WBC). Interestingly, previous studies on human subjects
showed a positive association between leukocyte counts
and levels of circulating triglycerides [54,55]. However,
in human epidemiological studies, the WBC count is
commonly used as a surrogate marker of subclinical
inflammation, a condition that is not present in HTG
experimental model.
Conclusions
Altogether, our results demonstrate that spleen mono-
nuclear cells from hyperlipidemic HTG mice have an
increased mitochondrial resting respiration rate due to
increased activity of the mitoKATP channel, which down-
regulates mitochondrial superoxide generation. The
increased levels of apoptosis in these cells are likely due
to both intrinsic and extrinsic pathways. The levels of
circulating lymphocytes are also reduced in HTG mice.
We propose that serum FFA in HTG mice induces a
cellular oxidized state that triggers apoptosis. The activa-
tion of mitoKATP is an adaptive response that increases
FFA oxidation and decreases mitochondrial superoxide
generation, which reduces the rates of the mitochondrial
arm of the apoptosis pathway.
Methods
Animals
The human apolipoprotein CIII transgenic (line 3707) [56]
founders were donated by Dr. Alan R. Tall (Columbia
University, NY) in 1996 and bred in the animal facilities of
the Department of Physiology and Biophysics, State
University of Campinas, SP, Brazil. Experiments were
approved by the University's Ethics Committee and are in
accordance with the Guidelines for Handling and Training
of Laboratory Animals published by the University’s Fed-
eration for Animal Welfare. Mice were housed at 22 ± 2°C
on a 12-h light–dark cycle and had access to standard
laboratory rodent chow (Nuvital CR1, Parana, Brazil) and
water ad libitum. Male and female heterozygous apolipo-
protein CIII transgenic (HTG) and non-transgenic (WT)
littermates, aged 3 to 6 months, were used in this study.
Transgenic mice presented fasting plasma triglyceride
levels over 300 mg/dL and WT below 100 mg/dL. Plasma
triglyceride levels were determined using an enzymatic-
colorimetric method (Chod-Pap, Roche Diagnostic
GmbH., Mannheim, Germany).
Isolation of spleen mononuclear cells
Spleens were gently homogenized in a Douncer manual
homogenizer. Spleen homogenates were overlaid onto a
Ficoll-PaqueTM PLUS layer with the density adjusted to
1.076 g/mL and centrifuged at 1000 × g at room
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temperature for 25 min. The interface cell layer was recov-
ered with a Pasteur pipette, washed twice in PBS and
centrifuged at 500 × g for 10 min [57]. Cells were counted
in a Neubauer chamber, using trypan blue to stain dead
cells. Cells were used when the viability was > 98%.
Determining oxygen consumption
Oxygen consumption was measured using a Clark-type
electrode (Hansatech Instruments Limited, Norfolk, UK)
in a 0.5 ml sealed glass cuvette equipped with a mag-
netic stirrer at 37°C. Reaction media for mitochondrial
respiration consisted of RPMI 1640 medium, 25 mM
HEPES pH 7.4, 1% FBS, 1 μg/ml oligomycin and 10 μM
diphenyleneiodonium (DPI).
Measuring intracellular reactive oxygen species (ROS)
levels
Intracellular ROS generation was measured using
1 μM H2-dichlorofluorescein-diacetate (H2DCF-DA)
[58] in a 1 mL cuvette with constant stirring at 37°C.
Reaction media for measuring ROS generation consisted
of HANKS medium pH 7.4 with 10 μM DPI. The fluor-
escence signal was recorded at the excitation/emission
wavelength pair of 488/525 nm using a fluorimeter
(Hitachi, model F4500). Calibration was performed with
known concentrations of dichlorofluorescein (DCF),
which is the product of H2-DCF oxidation.
Flow cytometry analysis of ROS release and cell death
Samples were analyzed in a FACSCalibur flow cytometer
(BD Biosciences, San Jose, CA, USA) equipped with an
argon laser and CellQuest software (version 4.1). Seven
to ten thousand events were acquired for each sample.
Spleen mononuclear cell populations were identified
according to their light-scattering characteristics and
enclosed in electronic gates, and the intensity of the
fluorescent probe signal was analyzed. Superoxide (O2
•-)
detection was estimated by measuring the oxidation of
dihydroethidium (DHE), as previously described [17].
Briefly, spleen mononuclear cells (106 cells.mL-1) were
incubated in RPMI 1640 medium containing 10% WT
or HTG serum at 37°C in a humidified CO2 incubator
(5% CO2) for 4 h. Next, cells were incubated with 5 μM
DHE for 45 min under the same conditions and ana-
lyzed in the flow cytometer (FL2 channel). To estimate
cell death, cells were suspended in binding buffer
(10 mM HEPES pH 7.4, 150 mM NaCl, 5 mM KCl,
1 mM MgCl2 and 1.8 mM CaCl2) containing annexin V-
FITC (1:500, Invitrogen, USA) and 7-amino-actinomycin
D (7-AAD, 20 μg/μL, Molecular Probes, USA). Apoptosis
was quantified as the number of annexin V-FITC-positive
(FL1 channel) and 7-AAD-negative cells (FL2 channel),
and necrosis was quantified as the number of 7-AAD-
positive and annexin V-FITC-negative cells.
Concentration of Interleukin-2
The concentration of endogenous interleukin-2 (IL-2)
in spleen mononuclear cells was measured using the
Endogen Mouse Interleukin-2 ELISA Kit (eBioscience),
according to the manufacturer’s recommended proce-
dure. Absorbance at 370 nm was determined using a
microplate reader (Labsystems Multiskan MS type 352,
Helsinki, Finland).
Measurement of cytosolic free Ca2+ concentrations
Cells (15 × 106 cells/mL) were loaded with 5 μM Fura-2
AM, a dual-wavelength radiometric indicator, in incuba-
tion medium containing 20 mM HEPES-Na buffer,
pH 7.4, 120 mM NaCl, 3 mM KCl, 0.5 mM KH2PO4,
5 mM NaHCO3, 1.2 mM Na2SO4, 10 mM glucose,
1.2 mM MgCl2, 1.3 mM CaCl2 and 30 μg/mL BSA for
40 min. The cytosolic free Ca2+ concentration in Fura-2-
loaded lymphocytes was determined at the excitation
wavelengths of 340 and 380 nm and an emission wave-
length of 510 nm using a fluorimeter (Hitachi, model
F4500). Calibration was performed at the end of each
experiment. [Ca2+]cyt was calculated using the dissoci-
ation constant (Kd) of 225 nM for Ca2+-Fura-2.
Detecting the mitochondrial cytochrome c released by
Western blotting
Mouse liver subcellular fractions were obtained using the
ProteoExtract Subcellular Proteome Extraction Kit, as
described by the manufacturer’s instructions (Calbiochem,
Darmstadt, Germany). The protein concentrations of
mitochondrial and cytosolic extracts were quantified
according to Bradford, 1976 [59]. Mitochondrial (5 μg
protein) and cytosolic (10 μg protein) fractions were
resolved by 12% SDS-PAGE and transferred onto a
polyvinyldiene difluoride membrane. The membrane was
blocked in 5% free fat free milk for 1 h and then incubated
with anti-cytochrome c primary antibody overnight at
4°C, followed by incubation with HRP-conjugated second-
ary antibody for 1 h at room temperature. The immune-
reactive bands were visualized using a chemiluminescence
detection kit (GE Health Care, Piscataway, NJ, USA). The
purity of the cytosolic fraction was determined by the
absence of a VDAC band.
Caspase 8 assay
Caspase 8 activity was assayed by measuring the release
of an AFC-fluorescent compound from the synthetic
peptide substrate Ac-LETD-AFC, using a Sigma kit and
following the manufacturer’s instructions (Sigma, Saint
Louis, Missouri, USA). Cells (3 × 106 cells.mL-1) were
suspended in 0.2 ml of chilled cell lysis buffer (20 mM
HEPES pH 7.5, 10 mM KCl, 250 mM sucrose, 2 mM
MgCl2 and 1 mM EDTA) containing 0.5 mM DTT. The
cell suspension was sonicated (Misonix Sonicator S-3000,
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New Highway Farmingdale, New York, USA) for 3 cycles
of 10 sec on ice at power setting 1; after that, cells were
frozen at −80°C. The cell lysates were then thawed and
centrifuged at 15,000 × g for 30 minutes. The supernatants
were added to 0.2 mL of reaction buffer (i.e., 25 mM
HEPES pH 7.5, 10% sucrose, 0.1% CHAPS) containing
10 mM DTT. Caspase 8 reactions were then initiated by
the addition of 0.1 mM Ac-LETD-AFC and incubated for
1.5 h at 37°C. Fluorescence was measured using a Hitachi
F4500 spectrofluorometer with excitation and emission
wavelengths of 400 nm and 505 nm, respectively, and a slit
width of 5.0 nm. Calibration was performed using free
AFC (Sigma), which is the product of cleaved peptide
substrate.
Cell counts
One milliliter of blood was obtained from the retro-orbital
plexus of anesthetized mice and stored in tubes containing
0.02 mL of the 7.5% ethylenediaminetetraacetic acid
(EDTA). Complete blood counts were taken within
an hour using a CELL-DYN 3700 SL analyzer (Abbott
Diagnostics, Chicago, USA).
Statistical analyses
Statistical analysis was performed using a one-way analysis
of variance for multiple comparisons with Tukey’s post-
hoc analysis (Figures 1, 2, 3, 5 and 6) and Student t-tests
(Figure 4 and Table 1). The level of significance was set at
P < 0.05. All data were analyzed using GraphPad Prism
software, version 5 (GraphPad Software, USA).
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